Search Results - "Poot, Alex"
-
1
Fluorine-18 labelled building blocks for PET tracer synthesis
Published in Chemical Society reviews (31-07-2017)“…Positron emission tomography (PET) is an important driver for present day healthcare. Fluorine-18 is the most widely used radioisotope for PET imaging and a…”
Get more information
Journal Article -
2
-
3
In Vivo Imaging of Glutamine Metabolism to the Oncometabolite 2-Hydroxyglutarate in IDH1/2 Mutant Tumors
Published in Cell metabolism (05-12-2017)“…The oncometabolite 2-hydroxyglutarate (2-HG) is a signature biomarker in various cancers, where it accumulates as a result of mutations in isocitrate…”
Get full text
Journal Article -
4
[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study
Published in European journal of nuclear medicine and molecular imaging (01-03-2023)“… Purpose Meta -[ 18 F]fluorobenzylguanidine ([ 18 F]mFBG) is a positron emission tomography (PET) radiotracer that allows for fast and high-resolution imaging…”
Get full text
Journal Article -
5
Comparison of the octadentate bifunctional chelator DFO-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
Published in European journal of nuclear medicine and molecular imaging (01-02-2017)“…Purpose All clinical 89 Zr-immuno-PET studies are currently performed with the chelator desferrioxamine (DFO). This chelator provides hexadentate coordination…”
Get full text
Journal Article -
6
Hyperpolarized [5- 13 C,4,4- 2 H 2 ,5- 15 N]-L-glutamine provides a means of annotating in vivo metabolic utilization of glutamine
Published in Proceedings of the National Academy of Sciences - PNAS (10-05-2022)“…Glutamine is consumed by rapidly proliferating cells and can provide the carbon and nitrogen required for growth through various metabolic pathways. However,…”
Get full text
Journal Article -
7
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
Published in Pharmaceuticals (Basel, Switzerland) (05-04-2022)“…Multiple small molecule PET tracers have been developed for the imaging of the epidermal growth factor receptor (EGFR). These tracers target the tyrosine…”
Get full text
Journal Article -
8
[ 68 Ga]Ga-RAYZ-8009: A Glypican-3-Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging-A First-in-Human Case Series
Published in Journal of Nuclear Medicine (01-10-2024)“…To date, the imaging and diagnosis of hepatocellular carcinoma (HCC) rely on CT/MRI, which have well-known limitations. Glypican-3 (GPC3) is a cell surface…”
Get full text
Journal Article -
9
From Carbon-11-Labeled Amino Acids to Peptides in Positron Emission Tomography: the Synthesis and Clinical Application
Published in Molecular imaging and biology (01-08-2018)“…Radiolabeled amino acids, their derivatives and peptides have a broad scope of application and can be used as receptor ligands, as well as enzyme substrates…”
Get full text
Journal Article -
10
In vivo imaging of TGFβ signalling components using positron emission tomography
Published in Drug discovery today (01-12-2019)“…•The transforming growth factor β (TGFβ) pathway is important in disease.•Imaging the TGFβ pathway is vital for understanding its role in disease.•An overview…”
Get full text
Journal Article -
11
Microfluidic Preparation of 89Zr-Radiolabelled Proteins by Flow Photochemistry
Published in Molecules (Basel, Switzerland) (02-02-2021)“…89Zr-radiolabelled proteins functionalised with desferrioxamine B are a cornerstone of diagnostic positron emission tomography. In the clinical setting,…”
Get full text
Journal Article -
12
Sentinel lymph node detection in thyroid carcinoma using [68Ga]Ga-tilmanocept PET/CT: a proof-of-concept study
Published in European journal of nuclear medicine and molecular imaging (01-01-2024)“…Purpose Sentinel lymph node (SLN) biopsy is rarely used for thyroid carcinoma staging. This is due to challenges associated with conventional Tc-99m-labeled…”
Get full text
Journal Article -
13
The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
Published in Frontiers in oncology (19-11-2020)“…In theranostics (i.e., therapy and diagnostics) radiopharmaceuticals are used for both therapeutic and diagnostic purposes by targeting one specific tumor…”
Get full text
Journal Article -
14
Stereocontrolled [11C]Alkylation of N‐Terminal Glycine Schiff Bases To Obtain Dipeptides
Published in European journal of organic chemistry (10-10-2017)“…The use of various quaternary ammonium salts as chiral phase‐transfer catalysts allowed effective and stereoselective radiochemical [11C]alkylation to obtain…”
Get full text
Journal Article -
15
Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging
Published in Lung cancer (Amsterdam, Netherlands) (01-05-2021)“…•18F-afatinib PET/CT is a safe tool to quantify 18F-afatinib uptake in NSCLC tumors.•Tumor uptake of 18F-afatinib is higher in EGFR mutated NSCLC versus wild…”
Get full text
Journal Article -
16
Evaluating the Targeting of a Staphylococcus-aureus -Infected Implant with a Radiolabeled Antibody In Vivo
Published in International journal of molecular sciences (22-02-2023)“…Implant infections caused by are difficult to treat due to biofilm formation, which complicates surgical and antibiotic treatment. We introduce an alternative…”
Get full text
Journal Article -
17
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor
Published in Nuclear medicine and biology (01-05-2023)“…Osimertinib is a third-generation tyrosine kinase inhibitor (TKI) that is able to inhibit the EGFR treatment resistance mutation T790M and primary EGFR…”
Get full text
Journal Article -
18
-
19
PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET
Published in Drug discovery today (01-11-2012)“…► Radiolabeling of TKIs. ► PET imaging of TKIs in drug development. ► TKI-PET as tool for personalized therapy. The discovery and increased understanding of…”
Get full text
Journal Article -
20
Design, Synthesis, Radiosynthesis and Biological Evaluation of Fenretinide Analogues as Anticancer and Metabolic Syndrome‐Preventive Agents
Published in ChemMedChem (19-08-2020)“…Fenretinide (4‐HPR) is a synthetic derivative of all‐trans‐retinoic acid (ATRA) characterised by improved therapeutic properties and toxicological profile…”
Get full text
Journal Article